Inventor · disambiguated record
Donald Kellerman
Also filed as: KELLERMAN DONALD · KELLERMAN DONALD J
7 granted patents·4 pending applications·21 citations·filing 2009–2023
78Inventor score
Files withMAP PHARMACEUTICALS INC3ZP OPCO INC3EMERGEX USA CORP2KELLERMAN DONALD J2ZOSANO PHARMA CORP1
Top patents by PatentIndex Score
11 records- 0190US9918932B2Method of rapidly achieving therapeutic concentrations of triptans for treatment of migrainesZP OPCO INC·Filed 2017·Granted Mar 20, 2018·5 cites·42 claims
- 0289US9394314B28′-hydroxy-dihydroergotamine compounds and compositionsMAP PHARMACEUTICALS INC·Filed 2013·Granted Jul 19, 2016·13 cites·11 claims
- 0384US11058630B2Method of rapidly achieving therapeutic concentrations of triptans for treatment of migrainesZOSANO PHARMA CORP·Filed 2018·Granted Jul 13, 2021·3 cites·36 claims
- 0465US11839683B2Method of rapidly achieving therapeutic concentrations of triptans for treatment of migrainesEMERGEX USA CORP·Filed 2021·Granted Dec 12, 2023·0 cites·15 claims
- 0559US8168597B2Method for treating cystic fibrosisKELLERMAN DONALD J·Filed 2009·Granted May 1, 2012·0 cites·15 claims
- 0656US11660265B2Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headachesZP OPCO INC·Filed 2019·Granted May 30, 2023·0 cites·21 claims
- 0756US2023255881A1Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headachesEMERGEX USA CORP·Filed 2023·Application pending·0 cites
- 0852US2016263101A18'-hydroxy-dihydroergotamine compounds and compositionsMAP PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0946US11660264B2Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headachesZP OPCO INC·Filed 2018·Granted May 30, 2023·0 cites·23 claims
- 1041US2015238412A1Administration of dihydroergotamine mesylate particles using a metered dose inhalerMAP PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1132US2011171141A1Administration of dihydroergotamine mesylate particles using a metered dose inhalerKELLERMAN DONALD J·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →